IBDEI2C0 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,39537,1,3,0)
 ;;=3^Central Retinal Vein Occlusion,Right Eye
 ;;^UTILITY(U,$J,358.3,39537,1,4,0)
 ;;=4^H34.811
 ;;^UTILITY(U,$J,358.3,39537,2)
 ;;=^5005568
 ;;^UTILITY(U,$J,358.3,39538,0)
 ;;=E11.321^^153^1926^66
 ;;^UTILITY(U,$J,358.3,39538,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39538,1,3,0)
 ;;=3^Type 2 DM w/ Mild Nonprolif DM Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,39538,1,4,0)
 ;;=4^E11.321
 ;;^UTILITY(U,$J,358.3,39538,2)
 ;;=^5002634
 ;;^UTILITY(U,$J,358.3,39539,0)
 ;;=E11.329^^153^1926^67
 ;;^UTILITY(U,$J,358.3,39539,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39539,1,3,0)
 ;;=3^Type 2 DM w/ Mild Nonprolif DM Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,39539,1,4,0)
 ;;=4^E11.329
 ;;^UTILITY(U,$J,358.3,39539,2)
 ;;=^5002635
 ;;^UTILITY(U,$J,358.3,39540,0)
 ;;=E11.331^^153^1926^68
 ;;^UTILITY(U,$J,358.3,39540,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39540,1,3,0)
 ;;=3^Type 2 DM w/ Mod Nonprolif DM Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,39540,1,4,0)
 ;;=4^E11.331
 ;;^UTILITY(U,$J,358.3,39540,2)
 ;;=^5002636
 ;;^UTILITY(U,$J,358.3,39541,0)
 ;;=E11.339^^153^1926^69
 ;;^UTILITY(U,$J,358.3,39541,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39541,1,3,0)
 ;;=3^Type 2 DM w/ Mod Nonprolif DM Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,39541,1,4,0)
 ;;=4^E11.339
 ;;^UTILITY(U,$J,358.3,39541,2)
 ;;=^5002637
 ;;^UTILITY(U,$J,358.3,39542,0)
 ;;=E11.351^^153^1926^70
 ;;^UTILITY(U,$J,358.3,39542,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39542,1,3,0)
 ;;=3^Type 2 DM w/ Prolif DM Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,39542,1,4,0)
 ;;=4^E11.351
 ;;^UTILITY(U,$J,358.3,39542,2)
 ;;=^5002640
 ;;^UTILITY(U,$J,358.3,39543,0)
 ;;=E11.359^^153^1926^71
 ;;^UTILITY(U,$J,358.3,39543,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39543,1,3,0)
 ;;=3^Type 2 DM w/ Prolif DM Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,39543,1,4,0)
 ;;=4^E11.359
 ;;^UTILITY(U,$J,358.3,39543,2)
 ;;=^5002641
 ;;^UTILITY(U,$J,358.3,39544,0)
 ;;=E11.341^^153^1926^72
 ;;^UTILITY(U,$J,358.3,39544,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39544,1,3,0)
 ;;=3^Type 2 DM w/ Severe Nonprolif DM Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,39544,1,4,0)
 ;;=4^E11.341
 ;;^UTILITY(U,$J,358.3,39544,2)
 ;;=^5002638
 ;;^UTILITY(U,$J,358.3,39545,0)
 ;;=E11.349^^153^1926^73
 ;;^UTILITY(U,$J,358.3,39545,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39545,1,3,0)
 ;;=3^Type 2 DM w/ Severe Nonprolif DM Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,39545,1,4,0)
 ;;=4^E11.349
 ;;^UTILITY(U,$J,358.3,39545,2)
 ;;=^5002639
 ;;^UTILITY(U,$J,358.3,39546,0)
 ;;=E11.9^^153^1926^74
 ;;^UTILITY(U,$J,358.3,39546,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39546,1,3,0)
 ;;=3^Type 2 DM w/o Complications
 ;;^UTILITY(U,$J,358.3,39546,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,39546,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,39547,0)
 ;;=H35.363^^153^1926^18
 ;;^UTILITY(U,$J,358.3,39547,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39547,1,3,0)
 ;;=3^Drusen of Macular,Bilateral
 ;;^UTILITY(U,$J,358.3,39547,1,4,0)
 ;;=4^H35.363
 ;;^UTILITY(U,$J,358.3,39547,2)
 ;;=^5005660
 ;;^UTILITY(U,$J,358.3,39548,0)
 ;;=H35.362^^153^1926^19
 ;;^UTILITY(U,$J,358.3,39548,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39548,1,3,0)
 ;;=3^Drusen of Macular,Left Eye
 ;;^UTILITY(U,$J,358.3,39548,1,4,0)
 ;;=4^H35.362
 ;;^UTILITY(U,$J,358.3,39548,2)
 ;;=^5005659
 ;;^UTILITY(U,$J,358.3,39549,0)
 ;;=H35.361^^153^1926^20
 ;;^UTILITY(U,$J,358.3,39549,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39549,1,3,0)
 ;;=3^Drusen of Macular,Right Eye
